To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Cracker Barrel CEO Julie Masino Steps Down After 'Woke' Rebranding Backlash

WNBA's Sophie Cunningham Backs Young Fans after Seattle Storm Co-Owner Cursed Them Out for Supporting Biological Reality (Video)

Christian PA Who Was Fired Over Transgender Referrals, Pronouns Wins $410K Settlement as Hospital Adopts New Policy

Boy George Chooses Truth Over the Anti-Israel Mob

Netanyahu Tells Christians: 'We Are One' (Video)

Florida Announces Investigation into Fauci Since His Pardon Isn't for State Charges

Prayer Alert: The First Lady and Barron Are Now in Iran's Crosshairs

DHS Arrested Over 900 Human Trafficking Suspects and Rescued 180 Victims during FIFA World Cup

Florida Evangelist Turning Defunct Vermont Campus into 'Christ-Centered University'

GenderSpeak: Weaponizing Gender Against Sex

Medical Schools Accused of Renaming DEI Offices to Avoid Scrutiny

Trump Administration Formally Bans Dangerous Gain-of-function Research

New Jersey Governor Refuses Noncitizen Voters' Data to Trump Administration, Calls Aliens 'Citizens'

Rand Paul Delivers a Cinematic Indictment of Anthony Fauci's COVID Legacy, While Fauci Pleads the Fifth (Video)

Islamic Regime in Iran Stage Public Executions of Innocent Protesters; Crickets from the UN and Human Rights Groups

Netanyahu Praises 'Excellent' Trump Meeting; IRGC Launches Surprise Attack on US Forces

'Craving the Truth': The Shocking Spiritual Hunger Sweeping Gen Z (Video)

'Unprecedented': AI Agent Escapes Secured Testing Environment and Hacks Another AI

University of Minnesota Medical School Develops Taxpayer-Funded 'Transgender' Dolls for Preschoolers

Trump Administration Asks Supreme Court to Allow Mail-in Ballot Restrictions

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor